Monday - October 26, 2026
Broad-developed technology powers an ultra-sensitive blood test for cancer DNA
October 26, 2026
CAMBRIDGE, Massachusetts, Oct. 26 [Category: Medical] -- The Broad Institute posted the following news:

* * *

Broad-developed technology powers an ultra-sensitive blood test for cancer DNA

*

The technology, MAESTRO, is at the heart of Abbott's new Oncodetect test, which detects extremely low levels of tumor DNA in a patient's blood sample, helping doctors detect cancer recurrence.

Highlights

* A product for c . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products